Target intelligence / Profile preview

Human immunodeficiency virus type 1 glycoprotein 41 N-terminal heptad repeat hydrophobic pocket (HIV-1 gp41 NHR hydrophobic pocket)

Target
HIV-1 gp41 NHR hydrophobic pocket
Molecular classification
Viral envelope protein, Fusion protein subunit, Type I transmembrane protein
01

Overview

The HIV-1 gp41 N-terminal heptad repeat (NHR) hydrophobic pocket is a highly conserved structural domain within the transmembrane subunit of the HIV-1 envelope glycoprotein (gp41). It plays a pivotal role during the fusion of the viral envelope with the host cell membrane, a process triggered by the binding of gp120 to CD4 and coreceptors (Chan et al., 1997). Upon activation, gp41 transitions into a pre-hairpin intermediate where three NHR segments form a central trimeric coiled-coil, creating a deep hydrophobic groove or pocket. This pocket serves as a critical docking site for the C-terminal heptad repeat (CHR) region; their interaction forms a stable six-helix bundle (6HB) that drives membrane apposition and fusion (Root et al., 2001). Because this pocket is essential for viral infectivity and highly conserved across diverse HIV-1 strains, it is a primary target for the development of fusion inhibitors. Drugs targeting this site, such as the peptide-based inhibitor Albuvirtide or experimental agents like T-1249, bind to the NHR coiled-coil and prevent the transition to the fusion-active state (Liu et al., 2007). This mechanism effectively halts the entry of HIV-1 into host CD4+ T cells, providing a therapeutic option for patients with multi-drug resistant infections.

Other names
gp41 hydrophobic pocketNHR hydrophobic pocketgp41 N-terminal heptad repeat pocketHIV-1 gp41 fusion pocketgp41 NHR groove
02

Mechanism of action

Inhibition of viral-cell membrane fusion by binding to the N-terminal heptad repeat (NHR) region of gp41, thereby preventing the formation of the six-helix bundle (6HB) required for entry.

03

Biological functions

Viral entry into host cellMembrane fusionViral envelope glycoprotein organizationProtein-protein interaction
04

Disease associations

HIV-1 infectionAcquired immunodeficiency syndrome
05

Safety considerations

Injection site reactionsHypersensitivity reactionsIncreased risk of bacterial pneumoniaRapid development of drug resistance if used as monotherapy
06

Interacting drugs

Enfuvirtide

3 more in the full profile.

07

Biomarkers

HIV-1 RNA viral loadCD4+ T-cell countgp41 NHR resistance mutations (e.g., G36D, V38A)

Beyond the preview

Go deeper on Human immunodeficiency virus type 1 glycoprotein 41 N-terminal heptad repeat hydrophobic pocket (HIV-1 gp41 NHR hydrophobic pocket).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human immunodeficiency virus type 1 glycoprotein 41 N-terminal heptad repeat hydrophobic pocket (HIV-1 gp41 NHR hydrophobic pocket).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call